Institutional Review Board
Mercy Health's Institutional Review Board
Mercy Health believes that research or clinical trials involving human subjects demand that our first responsibility is to the health and well-being of the individual. To protect and respect patient's rights, Mercy Health has established an Institutional Review Board (IRB).
Subject to FDA and HHS regulations, the IRB is an appropriately constituted group formally designated to review and monitor biomedical research involving human subjects. The purpose of the IRB is to assure, both in advance and by periodic review, that appropriate steps are taken to protect the rights and welfare of human subjects participating as subjects in research.
The IRB operates within Mercy Health's Mission, Values, Organizational Code of Ethics and the Religious and Ethical Directives for Catholic Health Care. The IRB's role is vital in the protection of human research subjects.
IRB review must take place before any research activity starts as it is the role of the IRB to assess the study's potential benefits and risks. You must not start your study until you have your IRB approval or exemption letter.
View our IRB policies and procedures >
If you have any questions about whether IRB review is required, please contact us at: GR-Research@mercyhealth.com.